{"title":"Predictive Value of Wells, Geneva, Bova, and PESI Scores in Elderly Pulmonary Embolism Patients.","authors":"Miray Tümer","doi":"10.12659/MSM.947238","DOIUrl":null,"url":null,"abstract":"<p><p>BACKGROUND This retrospective study aimed to compare the Wells score, Geneva score, Bova score, and Pulmonary Embolism Severity Index (PESI) in the prediction of 30-day mortality and survival outcomes in 200 geriatric patients with a diagnosis of pulmonary embolism (PE). MATERIAL AND METHODS We reviewed the records of 200 patients (≥65 years old) admitted to the Emergency Department between May 2019 and December 2019 with a diagnosis of PE confirmed by computed tomography pulmonary angiography. Demographic variables, comorbidities, mental status, and laboratory data were collected. The Wells score, Geneva score, Bova score, and PESI were calculated for each patient. Primary outcome was 30-day mortality. RESULTS Among these 200 elderly patients, the presence of malignancy (P<0.05) and altered mental status (P<0.05) were significantly associated with 30-day mortality. When analyzed categorically, only the PESI score showed a significant relationship with mortality (P<0.05). However, when considering numeric values, the Bova (P<0.001), Geneva (P=0.028), and PESI (P<0.001) scores all significantly predicted 30-day mortality. CONCLUSIONS The findings suggest that PESI alone is a strong predictor of short-term mortality when evaluated categorically, while Bova, Geneva, and PESI scores provide significant prognostic information in numeric form. This underscores the importance of detailed scoring in identifying high-risk older patients with PE, which can guide treatment decisions and potentially improve clinical outcomes.</p>","PeriodicalId":48888,"journal":{"name":"Medical Science Monitor","volume":"31 ","pages":"e947238"},"PeriodicalIF":3.1000,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11869490/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Science Monitor","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12659/MSM.947238","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
BACKGROUND This retrospective study aimed to compare the Wells score, Geneva score, Bova score, and Pulmonary Embolism Severity Index (PESI) in the prediction of 30-day mortality and survival outcomes in 200 geriatric patients with a diagnosis of pulmonary embolism (PE). MATERIAL AND METHODS We reviewed the records of 200 patients (≥65 years old) admitted to the Emergency Department between May 2019 and December 2019 with a diagnosis of PE confirmed by computed tomography pulmonary angiography. Demographic variables, comorbidities, mental status, and laboratory data were collected. The Wells score, Geneva score, Bova score, and PESI were calculated for each patient. Primary outcome was 30-day mortality. RESULTS Among these 200 elderly patients, the presence of malignancy (P<0.05) and altered mental status (P<0.05) were significantly associated with 30-day mortality. When analyzed categorically, only the PESI score showed a significant relationship with mortality (P<0.05). However, when considering numeric values, the Bova (P<0.001), Geneva (P=0.028), and PESI (P<0.001) scores all significantly predicted 30-day mortality. CONCLUSIONS The findings suggest that PESI alone is a strong predictor of short-term mortality when evaluated categorically, while Bova, Geneva, and PESI scores provide significant prognostic information in numeric form. This underscores the importance of detailed scoring in identifying high-risk older patients with PE, which can guide treatment decisions and potentially improve clinical outcomes.
期刊介绍:
Medical Science Monitor (MSM) established in 1995 is an international, peer-reviewed scientific journal which publishes original articles in Clinical Medicine and related disciplines such as Epidemiology and Population Studies, Product Investigations, Development of Laboratory Techniques :: Diagnostics and Medical Technology which enable presentation of research or review works in overlapping areas of medicine and technology such us (but not limited to): medical diagnostics, medical imaging systems, computer simulation of health and disease processes, new medical devices, etc. Reviews and Special Reports - papers may be accepted on the basis that they provide a systematic, critical and up-to-date overview of literature pertaining to research or clinical topics. Meta-analyses are considered as reviews. A special attention will be paid to a teaching value of a review paper.
Medical Science Monitor is internationally indexed in Thomson-Reuters Web of Science, Journals Citation Report (JCR), Science Citation Index Expanded (SCI), Index Medicus MEDLINE, PubMed, PMC, EMBASE/Excerpta Medica, Chemical Abstracts CAS and Index Copernicus.